JP2015522562A5 - - Google Patents

Download PDF

Info

Publication number
JP2015522562A5
JP2015522562A5 JP2015516391A JP2015516391A JP2015522562A5 JP 2015522562 A5 JP2015522562 A5 JP 2015522562A5 JP 2015516391 A JP2015516391 A JP 2015516391A JP 2015516391 A JP2015516391 A JP 2015516391A JP 2015522562 A5 JP2015522562 A5 JP 2015522562A5
Authority
JP
Japan
Prior art keywords
antibody
pharmaceutical composition
fragment
composition according
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015516391A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015522562A (ja
JP6430373B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2013/000569 external-priority patent/WO2013185215A1/en
Publication of JP2015522562A publication Critical patent/JP2015522562A/ja
Publication of JP2015522562A5 publication Critical patent/JP2015522562A5/ja
Application granted granted Critical
Publication of JP6430373B2 publication Critical patent/JP6430373B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015516391A 2012-06-12 2013-06-11 ミスフォールドプリオンタンパク質を標的とする抗体および複合体 Expired - Fee Related JP6430373B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261658569P 2012-06-12 2012-06-12
US61/658,569 2012-06-12
US201361809604P 2013-04-08 2013-04-08
US61/809,604 2013-04-08
PCT/CA2013/000569 WO2013185215A1 (en) 2012-06-12 2013-06-11 Antibodies and conjugates that target misfolded prion protein

Publications (3)

Publication Number Publication Date
JP2015522562A JP2015522562A (ja) 2015-08-06
JP2015522562A5 true JP2015522562A5 (enExample) 2016-08-04
JP6430373B2 JP6430373B2 (ja) 2018-11-28

Family

ID=49757359

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015516391A Expired - Fee Related JP6430373B2 (ja) 2012-06-12 2013-06-11 ミスフォールドプリオンタンパク質を標的とする抗体および複合体

Country Status (4)

Country Link
US (1) US9296819B2 (enExample)
JP (1) JP6430373B2 (enExample)
CA (1) CA2877505C (enExample)
WO (1) WO2013185215A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2642848C (en) 2006-03-03 2016-07-12 Amorfix Life Sciences Ltd. Methods and compositions to treat and detect misfolded-sod1 mediated diseases
AU2014252666B2 (en) * 2013-04-08 2017-02-02 Helix Biopharma Corp. Use of antibody-urease conjugates for diagnostic and therapeutic purposes
CA2922704A1 (en) 2013-05-24 2014-11-27 Neil R. Cashman Cell senescence markers as diagnostic and therapeutic targets
WO2016094715A2 (en) 2014-12-10 2016-06-16 Berkeley Lights, Inc. Movement and selection of micro-objects in a microfluidic apparatus
NZ733669A (en) * 2015-01-23 2019-03-29 Helix Biopharma Corp Antibody-urease conjugates for therapeutic purposes
KR102700777B1 (ko) * 2015-09-17 2024-08-29 이뮤노젠 아이엔씨 항-folr1 면역접합체를 포함하는 치료제 조합

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1048955A1 (zh) * 1999-06-23 2003-04-25 Idexx Laboratories, Inc. 朊病毒蛋白肽及其应用
NZ515982A (en) * 2000-12-08 2003-09-26 Fujirebio Kk Method and monoclonal antibodies for differentiation between abnormal and normal prions
US20070003977A1 (en) * 2003-08-20 2007-01-04 Amorfix Life Sciences Ltd Epitope protection assay and method for detecting protein conformations
US20100233176A1 (en) 2008-10-06 2010-09-16 Cashman Neil R Methods and systems for predicting misfolded protein epitopes

Similar Documents

Publication Publication Date Title
FI3332006T3 (fi) Uusia anti-PD-L1-vasta-aineita
JP2015522562A5 (enExample)
PH12018502623A1 (en) Anti-pd-l1 antibodies and uses thereof
JP2014205674A5 (enExample)
PH12020551173A1 (en) Anti-pd-l1 antibodies and uses thereof
JP2017048240A5 (enExample)
NZ625403A (en) Composition and method for diagnosis and treatment of diseases associated with neurite degeneration
JP2016537383A5 (enExample)
JP2015530971A5 (enExample)
NZ630433A (en) Antibodies and uses thereof to detect folate receptor 1
BR112013008765B8 (pt) Anticorpos monoclonais anti-tau humano isolados ou um fragmento de ligação à tau dos mesmos, métodos de preparação dos mesmos, polinucleotídeo ou polinucleotídeos, vetor ou vetores, composição, método in vitro de diagnóstico ou monitoramento da progressão de uma tauopatia neurodegenerativa em um indivíduo humano, método in vitro para diagnosticar uma tauopatia neurodegenerativa em um indivíduo humano, e kit útil para o diagnóstico de uma tauopatia neurodegenerativa
IL273196B2 (en) Claudin6 antibodies and methods of treating cancer
JP2013506428A5 (enExample)
JP2017176174A5 (enExample)
JP2017535257A5 (enExample)
JP2016511254A5 (enExample)
JP2015535828A5 (enExample)
JP2015514110A5 (enExample)
PH12014500089A1 (en) Antibodies that bind to ox40 and their uses
JP2013500940A5 (enExample)
JP2015503909A5 (enExample)
JP2013519364A5 (enExample)
EA032189B9 (ru) Изолированные человеческие моноклональные антитела против ингибитора пути тканевого фактора (tfpi) и фармацевтическая композиция, содержащая их
JP2015527365A5 (enExample)
JP2016509585A5 (enExample)